Pancreatic and hepatogenous diabetes: Specific aspects in pathophysiology and treatment;Pankreopriver und hepatogener diabetes: Besondere aspekte in pathophysiologie und behandlung

Internist

Volumn 42, Issue SUPPL. 1, 2001, Pages

  Siegel, E G ^a   Jakobs, R ^a   Riemann, J F ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALCOHOL; BIGUANIDE; C PEPTIDE; CYTOKINE; ENZYME; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLIBENCLAMIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE; GLUCOSE; INSULIN; INSULIN RECEPTOR; MIGLITOL; NORADRENALIN; PIOGLITAZONE; ROSIGLITAZONE; SOMATOMEDIN; SULFONYLUREA DERIVATIVE; SYNTHETASE; TRYPSIN; TRYPSINOGEN;

CHRONIC PANCREATITIS; DIABETES MELLITUS; HUMAN; INCIDENCE; INSULIN RESISTANCE; MORTALITY; PANCREAS CARCINOMA; PANCREAS RESECTION; PATHOPHYSIOLOGY; PREVALENCE; REVIEW;

CHRONIC DISEASE; DIABETES MELLITUS; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIVER CIRRHOSIS; PANCREAS; PANCREATITIS;

EID: 0035038646     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001080170002     Document Type: Review

References (73)

1. Effects of cytokines on the liver
2. Hypersecretion of proinsulin does not explain the hyperinsulinemia of patients with liver cirrhosis
3. Decreased glucagon receptors in diabetic rat hepatocytes
4. Correlative studies of growth hormone and insulin plasma concentration with metabolic abnormalities in acromegaly
5. Insulin-like Growth Factors and their binding proteins
6. Role of spontaneous portal-systemic shunting in hyperinsulinism of cirrhosis
7. The effect of growth hormone on glucose metabolism and insulin secretion in man
8. Insulin resistance in obese and nonobese man
9. Glucose tolerance in viral hepatitis
10. Cirrhosis and diabetes. Serum human growth hormone levels in Lennec's cirrhosis
11. Diabetes bei lebererkrankungen
12. Liver disease and glucose homeostasis
13. New developments in the incretin concept
14. Somatostatin infusion in liver cirrhosis; glucagon control of glucose homeostasis
15. Insulin resistance in liver cirrhosis: Decreased insulin binding to circulating monocytes
16. Decreased insulin binding to red blood cells in liver cirrhosis
17. Serum growth hormone-binding protein, insulin-like growth factor 1, and growth hormone in patients with liver cirrhosis
18. Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance
19. Hormonal and metabole changes in hepatic cirrhosis
20. Plasmakatecholaminspiegel bei lebererkrankungen
21. The relationship betweeen insulin sensitivity and skeletal muscle enzyme activities in liver cirrhosis
22. Glucose control in liver disease
23. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients
24. Differential effects of interleukin-1 and tumor necrosis factor on ketogenesis
25. Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis
26. 4-induced cirrhosis of rats
27. Insulin-like growth factor I and growth hormone in chronic liver disease
28. Altered control of growth hormone secretion in patients with cirrhosis of the liver
29. Preliminary studies of insulinotropic actions of glucagon-like peptide-1-(7-37) administration to diabetic and non-diabetic human subjects
30. Glykosurie und diabetes dutch experimentelle insulte und krankheiten der leber
31. Glucagon-like peptide-1, a new hormone of the entero-insulinar axis
32. Hepatic, gut and renal substrate flux rates in patients with hepatic cirrhosis
33. The glucose fatty-acid cycle does not explain the insulin resistance of cirrhosis
34. Glucose metabolism: A review with some perspectives for the future
35. Effect of hyperinsulinemia on glucose and lipid metabolism in cirrhosis
36. Glucose resistance contributes to diabetes mellitus in cirrhosis
37. Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis
38. Hyperinsulinemia and insulin resistance of cirrhosis: The importance of insulin hypersecretion
39. The glucose fatty acid cycle
40. Total and individual free fatty acid concentrations in liver cirrhosis
41. Glucose and fat metabolism during short term starvation in cirrhosis
42. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism
43. Growth hormone, IGF-I, and insulin resistance in cirrhosis
44. High Insulin-like growth factor binding protein 1 levels in cirrhosis: Link with insulin resistance
45. Growth hormone and carbohydrate intolerance in cirrhosis
46. Hyperglucagonemia in cirrhosis: Altered secretion and sensitivity to glucagon
47. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects
48. Insulin secretion defects in liver cirrhosis can be reversed by GLP-1 and its analogues. Studies in isolated rat islets
49. Hyperglucagonemia in cirrhosis
50. Serum levels of cytokines in chronic liver diseases
51. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: Implications for the management of diabetes
52. Einfluß von pankreatin auf den diabetes mellitus bei chronischer pankreatitis
53. Natural course in chronic pancreatitis
54. Metabolic control, and B-cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis
55. Diabetes and hypoglycemia in chronic pancreatitis
56. Hereditry pancreatitis is caused by a mutation in the cationic trypsinogen gene
57. Einfluß von pankreatin auf den diabetes mellitus bei chronischer pankreatitis
58. Klinik und prognose der chronischen pankreatitis
59. Endocrine changes in pancreatic insufficiency
60. Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhoea following enzyme substitution
61. Diabetes in chronic alcoholic pancreatitis. Role of residual cell function and insulin resistance
62. Diabetes mellitus secondary to chronic pancreatitis
63. A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma
64. Carcinoma of the pancreas. A clinical and pathologic study of 609 necropsied cases
65. Pancreatic cancer, alcohol, diabetes mellitus, and gallbladder disease
66. Diabetes and the risk of pancreatic cancer
67. Sekundärer diabetes bei chronischer pankreatitis
68. Insulin and c-peptide plasma levels in patients with severe chronic panacreatitis and fasting normoglycemia
69. Sekundärer diabetes beim pankreaskarzinom und nach pankreasresektion: Pathophysiologie, therapeutische besonderheiten und prognose
70. The natural history of pain in alcoholic chronic pancreatitis
71. Risk factors for diabetes mellitus in chronic pancreatitis
72. Glucose homeostasis and endocrine pancreatic function in patients with chronic pancreatitis before and after surgical therapy
73. Randomized trial of duodenum-preserving pancreatic head resection versus pyloruspreserving whipple in chronic pancreatitis